Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines.
Oncoimmunology. 2017 Jan 11;6(3):e1277306. doi: 10.1080/2162402X.2016.1277306. eCollection 2017.
Oncoimmunology. 2017.
PMID: 28405498
Free PMC article.
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors.
Bacac M, Fauti T, Sam J, Colombetti S, Weinzierl T, Ouaret D, Bodmer W, Lehmann S, Hofer T, Hosse RJ, Moessner E, Ast O, Bruenker P, Grau-Richards S, Schaller T, Seidl A, Gerdes C, Perro M, Nicolini V, Steinhoff N, Dudal S, Neumann S, von Hirschheydt T, Jaeger C, Saro J, Karanikas V, Klein C, Umaña P.
Bacac M, et al. Among authors: saro j.
Clin Cancer Res. 2016 Jul 1;22(13):3286-97. doi: 10.1158/1078-0432.CCR-15-1696. Epub 2016 Feb 9.
Clin Cancer Res. 2016.
PMID: 26861458
Item in Clipboard
89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding.
van Brummelen EMJ, Huisman MC, de Wit-van der Veen LJ, Nayak TK, Stokkel MPM, Mulder ER, Hoekstra OS, Vugts DJ, Van Dongen GAMS, Verheul HM, Evers S, Tessier JJL, Saro J, Schellens JHM, Menke-van der Houven van Oordt CW.
van Brummelen EMJ, et al. Among authors: saro j.
Oncotarget. 2018 May 15;9(37):24737-24749. doi: 10.18632/oncotarget.25343. eCollection 2018 May 15.
Oncotarget. 2018.
PMID: 29872502
Free PMC article.
Item in Clipboard
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors.
Peters S, Angevin E, Alonso-Gordoa T, Rohrberg K, Melero I, Mellado B, Perez-Gracia JL, Tabernero J, Adessi C, Boetsch C, Watson C, Dal Porto J, Dejardin D, Del Nagro C, Nicolini V, Evers S, Klein C, Leutgeb B, Pisa P, Rossmann E, Saro J, Umana P, Charo J, Teichgräber V, Steeghs N.
Peters S, et al. Among authors: saro j.
Clin Cancer Res. 2024 Apr 15;30(8):1630-1641. doi: 10.1158/1078-0432.CCR-23-2658.
Clin Cancer Res. 2024.
PMID: 38319672
Item in Clipboard
Risk factors associated with stress urinary incontinence 12 years after first delivery.
Arrue Gabilondo M, Ginto L, Zubikarai M, Galán C, Saro J, Diez-Itza I.
Arrue Gabilondo M, et al. Among authors: saro j.
Int Urogynecol J. 2021 Nov;32(11):3061-3067. doi: 10.1007/s00192-020-04661-2. Epub 2021 Jan 20.
Int Urogynecol J. 2021.
PMID: 33471145
Item in Clipboard
Factors involved in the persistence of stress urinary incontinence from postpartum to 12 years after first delivery.
Diez-Itza I, Zubikarai M, Galan C, Ginto L, Saro J, Arrue M.
Diez-Itza I, et al. Among authors: saro j.
Neurourol Urodyn. 2020 Aug;39(6):1849-1855. doi: 10.1002/nau.24442. Epub 2020 Jun 19.
Neurourol Urodyn. 2020.
PMID: 32558998
Item in Clipboard
First pass evaluation of blood velocity in the pulmonary artery.
Saro JP, Rafael JA, De Lima JJ, Botelho MF, Ribeiro MJ.
Saro JP, et al.
Nucl Med Commun. 2001 Jul;22(7):813-6. doi: 10.1097/00006231-200107000-00013.
Nucl Med Commun. 2001.
PMID: 11453055
Item in Clipboard
Cite
Cite